The Enterprise Value as of November 2024 (TTM) for Geron Corporation (GERN) is 2.42B

According to Geron Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 2.42B. This represents a change of 9.22% compared to the average of 2.21B of the last 4 quarters.

Geron Corporation (GERN) Historical Enterprise Value (quarterly & annually)

How has GERN Enterprise Value performed in the past?

The mean historical Enterprise Value of Geron Corporation over the last ten years is 520.81M. The current 2.42B Enterprise Value has changed 46.28% with respect to the historical average. Over the past ten years (40 quarters), GERN's Enterprise Value was at its highest in in the September 2024 quarter at 2.96B. The Enterprise Value was at its lowest in in the December 2018 quarter at 175.50M.

Geron Corporation (GERN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Geron Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Geron Corporation (GERN) Average Enterprise Value

How has GERN Enterprise Value performed in the past?

The current Enterprise Value of Geron Corporation (GERN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Geron Corporation (GERN) Enterprise Value vs. Peers

How is GERN’s Enterprise Value compared to its peers?

Geron Corporation’s Enterprise Value is less than Viking Therapeutics, Inc. (0), less than TG Therapeutics, Inc. (5.81B), less than X4 Pharmaceuticals, Inc. (5.52B), greater than PDS Biotechnology Corporation (38.44M), greater than Madrigal Pharmaceuticals, Inc. (53.10M), less than Zura Bio Limited (7.46B), greater than Enveric Biosciences, Inc. (-9969663.00), greater than eFFECTOR Therapeutics, Inc. (202.96K), greater than Immix Biopharma, Inc. (4.74M), greater than Elevation Oncology, Inc. (30.53M), greater than Sarepta Therapeutics, Inc. (18.49M), less than Hepion Pharmaceuticals, Inc. (12.11B), greater than PTC Therapeutics, Inc. (5.35M), less than CohBar, Inc. (3.21B), greater than Ocean Biomedical, Inc. (-4477266.00), greater than AVROBIO, Inc. (35.97M), greater than null (-85302404.00),

Build a custom stock screener for Geron Corporation (GERN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Geron Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Geron Corporation (GERN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Geron Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.